Gufic Biosciences [GUFICBIO] vs Sun Pharma Advanced [SPARC] Detailed Stock Comparison

Gufic Biosciences Ltd.

NSE
Loading...

Sun Pharma Advanced Research Company Ltd.

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Gufic Biosciences Ltd. wins in 15 metrics, Sun Pharma Advanced Research Company Ltd. wins in 3 metrics, with 0 ties. Gufic Biosciences Ltd. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Gufic Biosciences Ltd. Sun Pharma Advanced Research Company Ltd. Better
P/E Ratio (TTM) 58.40 -13.65 Gufic Biosciences Ltd.
Price-to-Book Ratio 4.61 -13.55 Gufic Biosciences Ltd.
Debt-to-Equity Ratio 58.50 -1.21 Gufic Biosciences Ltd.
PEG Ratio -1.63 -11.15 Gufic Biosciences Ltd.
EV/EBITDA 26.66 -22.27 Gufic Biosciences Ltd.
Profit Margin (TTM) 5.58% -53.22% Gufic Biosciences Ltd.
Operating Margin (TTM) 10.93% -700.71% Gufic Biosciences Ltd.
EBITDA Margin (TTM) 10.93% N/A N/A
Return on Equity 11.59% 157.88% Sun Pharma Advanced Research Company Ltd.
Return on Assets (TTM) 5.96% -102.08% Gufic Biosciences Ltd.
Free Cash Flow (TTM) $470.42M $-3.71B Gufic Biosciences Ltd.
Dividend Yield 0.03% N/A N/A
1-Year Return 0.16% 34.88% Sun Pharma Advanced Research Company Ltd.
Price-to-Sales Ratio (TTM) 3.25 87.98 Gufic Biosciences Ltd.
Enterprise Value $31.95B $50.87B Sun Pharma Advanced Research Company Ltd.
EV/Revenue Ratio 3.56 95.73 Gufic Biosciences Ltd.
Gross Profit Margin (TTM) 56.35% -59.53% Gufic Biosciences Ltd.
Revenue per Share (TTM) $89 $2 Gufic Biosciences Ltd.
Earnings per Share (Diluted) $4.97 $-8.25 Gufic Biosciences Ltd.
Beta (Stock Volatility) -0.08 0.19 Gufic Biosciences Ltd.

Gufic Biosciences Ltd. vs Sun Pharma Advanced Research Company Ltd. Stock Performance Analysis

Loading Price Chart...

GUFICBIO
SPARC

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Gufic Biosciences Ltd.-2.92%-4.33%27.80%27.53%3.28%5.57%
Sun Pharma Advanced Research Company Ltd.2.36%12.49%39.95%100.62%67.89%69.61%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Gufic Biosciences Ltd.0.16%60.19%111.36%689.05%4,721.43%4,540.63%
Sun Pharma Advanced Research Company Ltd.34.88%14.54%-3.55%-20.47%148.26%-23.02%

Performance & Financial Health Analysis: Gufic Biosciences Ltd. vs Sun Pharma Advanced Research Company Ltd.

MetricGUFICBIOSPARC
Market Information
Market Cap i₹29.80B₹46.75B
Market Cap CategorySmall capSmall cap
10 Day Avg. Volume i41,8862,401,062
90 Day Avg. Volume i52,5342,083,443
Last Close₹360.40₹229.03
52 Week Range₹268.00 - ₹407.85₹108.00 - ₹248.75
% from 52W High-11.63%-7.93%
All-Time High₹26,990.00 (Oct 30, 2023)₹875.00 (Apr 24, 2006)
% from All-Time High-98.66%-73.83%
Growth Metrics
Quarterly Revenue Growth0.11%-0.43%
Quarterly Earnings Growth-0.36%-0.43%
Financial Health
Profit Margin (TTM) i0.06%-0.53%
Operating Margin (TTM) i0.11%-7.01%
Return on Equity (TTM) i0.12%1.58%
Debt to Equity (MRQ) i58.50-1.21
Cash & Liquidity
Book Value per Share (MRQ)₹63.02₹-10.63
Cash per Share (MRQ)₹8.79₹0.03
Operating Cash Flow (TTM) i₹834.72M₹-3,484,287,000
Levered Free Cash Flow (TTM) i₹696.50M₹-3,425,094,000
Dividends
Last 12-Month Dividend Yield i0.03%N/A
Last 12-Month Dividend i₹0.10N/A

Valuation & Enterprise Metrics Analysis: Gufic Biosciences Ltd. vs Sun Pharma Advanced Research Company Ltd.

MetricGUFICBIO (Apr 24, 2026)SPARC (Apr 22, 2026)
Price Ratios
P/E Ratio (TTM) i58.40-13.65
Forward P/E iN/A2.60
PEG Ratio i-1.63-11.15
Price to Sales (TTM) i3.2587.98
Price to Book (MRQ) i4.61-13.55
Market Capitalization
Market Capitalization i₹29.80B₹46.75B
Enterprise Value i₹31.95B₹50.87B
Enterprise Value Metrics
Enterprise to Revenue i3.5695.73
Enterprise to EBITDA i26.66-22.27
Risk & Other Metrics
Beta i-0.080.19
Book Value per Share (MRQ) i₹63.02₹-10.63

Financial Statements Comparison: Gufic Biosciences Ltd. vs Sun Pharma Advanced Research Company Ltd.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricGUFICBIO (2025)SPARC (2025)
Revenue/Sales i7.46B717.66M
Cost of Goods Sold i3.82B1.10B
COGS % of Revenue i51.3%153.2%
Gross Profit i3.63B-381.94M
Gross Margin i48.7%-53.2%
Research & Development i56.10MN/A
Operating Income (EBIT) i1.17B-3.34B
Operating Margin i15.7%-465.5%
EBITDA i1.38B-3.23B
EBITDA Margin i18.5%-450.0%
Pre-Tax Income i941.44M-3.43B
Pre-Tax Income % of Revenue i12.6%-477.6%
Income Tax i244.95M-2.72M
Income Tax % of Revenue i3.3%-0.4%
Net Income (Profit) i696.49M-3.43B
Profit Margin i9.3%-477.3%

Balance Sheet & Liquidity Metrics

MetricGUFICBIO (2025)SPARC (2025)
Cash & Equivalents i157.23M19.64M
Total Current Assets i6.25B261.97M
Total Current Assets % of Revenue i83.8%36.5%
Total Current Liabilities i3.88B3.74B
Total Current Liabilities % of Revenue i52.0%521.5%
Long-Term Debt i1.50B1.07B
Long-Term Debt % of Revenue i20.1%149.0%
Total Shareholders Equity i6.01B-2.17B
Retained Earnings i4.21B-23.22B
Retained Earnings % of Revenue i56.5%-3,235.0%
Property, Plant & Equipment i200.36M178.02M

Cash Flow Statement Comparison

MetricGUFICBIO (2025)SPARC (2025)
Operating Cash Flow i834.72M-3.48B
Operating Cash Flow % of Revenue i11.2%-485.5%
Capital Expenditures i-707.59M-97.45M
Free Cash Flow i470.42M-3.71B
FCF Margin i6.3%-516.4%
Debt Repayment i-235.47M-3.69B
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricGUFICBIOSPARC
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Shares Outstanding i100.28M324.52M
Float Shares i25.84M91.32M
% Held by Insiders i77.54%72.96%
% Held by Institutions i3.65%2.56%
% Held by Public i18.81%24.48%

Dividend Analysis & Yield Comparison: Gufic Biosciences Ltd. vs Sun Pharma Advanced Research Company Ltd.

MetricGUFICBIOSPARC
Last 12-Month Dividend i₹0.10N/A
Last 12-Month Dividend Yield i0.03%N/A
3-Year Avg Annual Dividend i₹0.13N/A
3-Year Avg Dividend Yield i0.04%N/A
3-Year Total Dividends i₹0.40N/A
Ex-Dividend DateSep 22, 2025N/A